Dublin, Aug. 23, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of Wintergreen Research, Inc's new report "Patient Monitor Equipment: Market Strategies and Forecasts, Worldwide, 2016-2022" to their offering.
Patient monitor markets at $11 billion in 2015 are anticipated to reach $26.2 billion by 2022
Strong growth is predicated on the increasing reliance on multi-parameter patient monitors in every bed of the hospital, in multiple areas of specialized clinics, and in many rehab centers.
Worldwide Patient Monitoring markets are poised to achieve significant growth as a resurgence in tracking vital signs extends from the intensive care unit ICU and emergency department to all areas of the hospital, to patient transport venues, and to home outpatient treatment locations.
The patient monitoring platform is modular, integrating various components. Modular systems are developed in the context of consideration of probable specifications for the interaction of system components. Patient Monitoring systems are making a market resurgence because smaller, lighter, wireless units are less costly and more valuable in the context of treatment evaluations and recommendations. People who have cardiac or respiratory difficulty have more treatment options, making more extensive patient monitoring useful.
Designs take into consideration users with mild, moderate, and severe chronic disease condition restrictions. Users come from chronic disease groups and older age groups. The core of a patient monitoring platform is an integration of separate vital signs detection sensors that form a system that supports adapting to numerous clinical requirements.
Modules implement ways to determine patient condition. Market driving forces for multi-parameter and specialized vital signs patient monitors = relate to more societal willingness to pay for vigilance, an increase in vigilance of sick people at risk. Cardiac and respiratory symptoms are measured as vital sign shifts by patient monitors.
Symptoms are represented by shifts in vital sign monitoring that measures disease conditions impacted deterioration of patient well-being. The monitoring is frequently done in conjunction with blood work. There is a lot of complexity in determining the meaning of the patient monitor vital signs measurements. Shortness of breath is a common symptom of cardiac disease. It is frequently misdiagnosed as a respiratory symptom or ignored by patients and is not even considered a symptom.
Key Topics Covered:
1. Patient Monitoring Market Description and Market Dynamics
2. Patient Monitoring Systems Market Shares and Market Forecast
3. Patient Monitoring Products
4. Patient Monitoring Research and Technology
5. Patient Monitoring Company Description
Companies Mentioned
- AMD Global Telemedicine
- Abbott Labs
- Alten Calsoft Labs
- American Telecare
- BPL Group / Penlon
- Biotronic
- Boston Scientific
- CardioNet
- Cardiocom
- Care Innovations
- Criticare Systems
- Criticare Technologies
- Drager
- Fukuda Denshi
- General Electric (GE)
- Getinge Group / Maquet
- Guangdong Biolight Meditech Co.,
- HealthSense
- Hill-Rom / Welch Allyn
- Honeywell
- Infinium
- LifeWatch
- Ltd.
- Maquet
- Medtronic
- Mindray Medical
- Mortara Instrument
- NSD / Viterion
- Nihon Kohden
- OSI / Spacelabs
- Opto Circuits
- Penlon
- Philips
- Qualcomm Incorporated
- Roche
- Schiller
- Smiths Medical
- Sotera
- Sotera Wireless
- St. Jude Medical
- Vitaphone
- Viterion
- eCaring
For more information about this http://www.researchandmarkets.com/research/vj2dwg/patient_monitor
Related Topics: Medical Devices
Source: Wintergreen Research, Inc